Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
13.08. | Merck begins 8% workforce purge, laying off 58 at its New Jersey HQ | ||
12.08. | Eli Lilly pledges vigorous defense as Texas sues over alleged drug kickbacks | ||
12.08. | Biohaven trashes troriluzole in OCD after asset bungles phase 3 trial | ||
12.08. | AbbVie plans $195M API plant in Illinois as part of US investment campaign | ||
12.08. | Endo returns to its roots, building on 'Bent Carrot' campaign for fresh Xiaflex push | ||
12.08. | Pfizer and Astellas' Padcev, plus Keytruda, delivers 'breakthrough' win in new bladder cancer use | ||
12.08. | In wake of Trump's request for direct drug sales, BlinkRx debuts off-the-shelf DTC platform for pharmas | ||
12.08. | Summit skips routine quarterly investor call as deal rumors swirl | ||
12.08. | FDA may not renew Pfizer's pediatric COVID shot authorization, prompting potential complication for child vaccinations this fall | ||
12.08. | Medical device, pharma packaging specialist Sanner makes CEO change amid growth push | ||
11.08. | Cold Chain Technologies to eliminate 82 jobs at HQ in Massachusetts | ||
09.08. | Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time? | ||
08.08. | CDC campaign targeting substance use, mental health tells teens to 'Free Your Mind' | ||
08.08. | Amid excitement over Yeztugo, Gilead sees continued erosion of CAR-T sales | ||
08.08. | FDA restricts bluebird bio gene therapy Skysona after blood cancer reports | ||
08.08. | GSK collects $320M as BioNTech, Pfizer settle mRNA patent spat with CureVac | ||
08.08. | Fierce Pharma Asia-Sanofi pulls Praluent in China; Trump updates drug tariff threat; An early-stage capital crunch | ||
08.08. | Is Trump's MFN pricing order more bark than bite? | ||
08.08. | Trial results set up AbbVie, Genmab's Epkinly for key expansion in follicular lymphoma | ||
07.08. | Amid pharma's US investment spree, FDA unveils new program to streamline domestic plant build-outs | ||
07.08. | Novo Nordisk's US marketing head Ulrich Otte steps down | ||
07.08. | CorMedix expands infectious disease portfolio with $300M acquisition of Melinta | ||
07.08. | Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds' | ||
07.08. | FDA tightens label of Valneva's chikungunya vaccine, lifts pause in older adults | ||
07.08. | Vor Bio hires commercial chief, reuniting ex-Sarepta colleagues in freshly rebuilt C-suite |